CEO and Cofounder of RDMD
Nancy is the CEO and Cofounder of RDMD. She was previously Head of Corporate Development at 23andMe, where she led efforts to advance the next generation sequencing platform, drug discovery strategy, and business development programs. Before that, she was a biotechnology investment banker on Wall Street. She's passionate about bridging the gap between patients and industry to make drug R&D cheaper, faster, and better. Nancy has a dual degree in Molecular Biology and Finance and Economics from University of Pennsylvania and the Wharton School of Business.